Omron (OMRNY)
(Delayed Data from OTC)
$35.32 USD
-1.13 (-3.10%)
Updated May 16, 2024 03:47 PM ET
5-Strong Sell of 5 5
F Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for Omron Corp falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 5,671 | 6,483 | 6,790 | 6,162 | 6,237 |
Cost Of Goods | NA | 3,568 | 3,703 | 3,357 | 3,443 |
Gross Profit | NA | 2,915 | 3,087 | 2,805 | 2,794 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 2,170 | 2,292 | 2,217 | 2,290 |
Income After Depreciation & Amortization | 0 | 745 | 795 | 587 | 504 |
Non-Operating Income | NA | -17 | -23 | 25 | -27 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | 728 | 772 | 612 | 477 |
Income Taxes | NA | 185 | 205 | 142 | 104 |
Minority Interest | NA | 5 | 6 | 6 | 4 |
Investment Gains/Losses | NA | 8 | -14 | -57 | -9 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 56 | 552 | 552 | 413 | 364 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 329 |
Net Income (GAAP) | 56 | 547 | 546 | 407 | 689 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 942 | 1,003 | 801 | 767 |
Depreciation & Amortization (Cash Flow) | NA | 197 | 208 | 214 | 263 |
Income After Depreciation & Amortization | 0 | 745 | 795 | 587 | 504 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 196.87 | 198.45 | 200.88 | 201.69 | NA |
Diluted EPS Before Non-Recurring Items | 0.29 | 2.75 | 2.72 | 2.02 | NA |
Diluted Net EPS (GAAP) | 0.29 | 2.75 | 2.72 | 2.02 | NA |
Fiscal Year end for Omron Corp falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 1,420.21 | 1,403.91 | 1,365.67 | 1,484.46 | 1,800.55 |
Cost Of Goods | NA | NA | NA | 823.45 | NA |
Gross Profit | NA | NA | NA | 661.02 | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 556.60 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 104.42 | 0.00 |
Non-Operating Income | NA | NA | NA | 31.08 | NA |
Interest Expense | NA | NA | NA | 0.00 | NA |
Pretax Income | NA | NA | NA | 135.50 | NA |
Income Taxes | NA | NA | NA | 32.29 | NA |
Minority Interest | NA | NA | NA | 1.31 | NA |
Investment Gains/Losses | NA | NA | NA | -4.10 | NA |
Other Income/Charges | NA | NA | NA | 0.00 | NA |
Income From Cont. Operations | 1.73 | 11.98 | -50.63 | 99.10 | 176.53 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 1.73 | 11.98 | -50.63 | 97.79 | 176.53 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 196.92 | 196.99 | 196.88 | 196.86 | 197.41 |
Diluted EPS Before Non-Recurring Items | 0.01 | 0.06 | -0.26 | 0.50 | 0.89 |
Diluted Net EPS (GAAP) | 0.01 | 0.06 | -0.26 | 0.50 | 0.89 |